Silexion Therapeutics Corp

SLXN · XNAS

CIK 2022416fmd_1EC25RB7AFASA7JMB5ZMH6G2QNManufacturing · Biological Products, (No Diagnostic Substances)Template: Standard

Coverage: Jan 01, 2023 to Sep 30, 2026, 14 periods

AI-written

A model wrote this from the company's own SEC filings and our standardized facts. It is not reported fact, not an analyst's estimate, not a rating and not investment advice. Every claim shows what it rests on.